<!--
Filename: 	Stomach.md
Project: 	/Users/shume/Developer/mnemosyne/docs/MMB/docs/a_GE
Author: 	shumez <https://github.com/shumez>
Created: 	2019-04-03 17:16:7
Modified: 	2019-08-28 16:40:45
-----
Copyright (c) 2019 shumez
-->

# Stomach

## AGML

Acute Gastric Mucosal Lesion 急性胃粘膜病変

<!-- <h6 id='agml-def'>Definition</h6> -->
<h6 id='agml-eti'>Etiology</h6>

- &darr; 胃粘膜血流

<!-- <h6 id='agml-epi'>Epidemiology</h6> -->
<h6 id='agml-cls'>Classification</h6>

- 薬物
	- NSAIDs
		- インドメタシン
		- アスピリン
		- フェニルブタゾン
	- ABx
	- steroid
	- alcohol
- ストレス
	- **Curling ulcer**
		- 重症熱傷
	- Cushing ulcer
		- 頭部損傷
	- 精神的ストレス
- 感染
	- virus
		- CMV
		- HSV
	- 細菌
	- HP
- 医原性
	- 内視鏡検査後のHP感染
	- TAE (肝動脈側線療法)
- 異物

<!-- <h6 id='agml-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='agml-ass'>Association</h6> -->
<!-- <h6 id='agml-ex'>Examination</h6> -->
<!-- <h6 id='agml-dx'>Diagnosis</h6> -->
<!-- <h6 id='agml-tx'>Treatment</h6> -->
<!-- <h6 id='agml-prg'>Prognosis</h6> -->
<!-- <h6 id='agml-app'>Appendix</h6> -->


## Chronic Gastritis

<!-- <h6 id='chronic_gastritis-def'>Definition</h6> -->
<h6 id='chronic_gastritis-eti'>Etiology</h6>

- HP感染

<!-- <h6 id='chronic_gastritis-epi'>Epidemiology</h6> -->
<h6 id='chronic_gastritis-cls'>Classification</h6>

**Strickland-Mackay**

<table class="table table-condensed">
	<thead>
		<tr>
			<th width="20%"></th>
			<th width="40%">A型</th>
			<th width="40%">B型</th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th>病態</th>
			<td align="center">自己免疫</td>
			<td align="center"><i>HP</i></td>
		</tr>
		<tr>
			<th>Gastrin</th>
			<td align="center">&uarr;&uarr;</td>
			<td align="center">&rarr;</td>
		</tr>
		<tr>
			<th>胃酸</th>
			<td align="center">&darr;&darr;</td>
			<td align="center">&rarr;</td>
		</tr>
	</tbody>
</table>

<!-- <h6 id='chronic_gastritis-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='chronic_gastritis-ass'>Association</h6> -->
<h6 id='chronic_gastritis-ex'>Examination</h6>

- 内視鏡
	- 表層性胃炎
		- 稜線状発赤
	- 萎縮性胃炎
		- **血管透過像**
		- 菲薄化, 褪色調粘膜

<!-- <h6 id='chronic_gastritis-dx'>Diagnosis</h6> -->
<!-- <h6 id='chronic_gastritis-tx'>Treatment</h6> -->
<!-- <h6 id='chronic_gastritis-prg'>Prognosis</h6> -->
<!-- <h6 id='chronic_gastritis-app'>Appendix</h6> -->

### Helicobacter pylori

<!-- <h6 id='helicobacter_pylori-def'>Definition</h6> -->

<h6 id='helicobacter_pylori-eti'>Etiology</h6>

- \( \text{CO(NH}_2)_2 + 2\text{H}^+ + \text{H}_2\text{O} \, \xrightarrow[\text{Urease}] \, \text{CO}_2 + 2\text{NH}_4^+ \)

<!-- <h6 id='helicobacter_pylori-epi'>Epidemiology</h6> -->
<!-- <h6 id='helicobacter_pylori-cls'>Classification</h6> -->
<!-- <h6 id='helicobacter_pylori-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='helicobacter_pylori-ass'>Association</h6> -->

<h6 id='helicobacter_pylori-ex'>Examination</h6>

[![](https://upload.wikimedia.org/wikipedia/commons/a/af/Immunohistochemical_detection_of_Helicobacter_%281%29_histopatholgy.jpg)](https://upload.wikimedia.org/wikipedia/commons/a/af/Immunohistochemical_detection_of_Helicobacter_%281%29_histopatholgy.jpg)

- **迅速ウレアーゼ試験**
- **^13^C尿素呼気試験**

<!-- <h6 id='helicobacter_pylori-dx'>Diagnosis</h6> -->
<h6 id='helicobacter_pylori-tx'>Treatment</h6>

- 初回
	- **PPI** / P-CAB
	- **CAM** (**クラリスロマイシン**)
	- **AMPC** (**アモキシシリン**)
- 二次
	- PPI / P-CAB
	- MNZ (メトロニダゾール)
	- AMPC

**K^+^競合型**: P-CAB (Pottassium-competitive acid blockade) (Vonoprazan タケキャブ)

<!-- <h6 id='helicobacter_pylori-prg'>Prognosis</h6> -->
<!-- <h6 id='helicobacter_pylori-app'>Appendix</h6> -->


## FD

**Definition**

* FGID
	* GERD
	* FD
	* IBS
	
<!-- **Etiology** -->
<!-- *  -->
<!-- **Epidemiology** -->
<!-- *  -->
<!-- **Classification** -->
<!-- *  -->
<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->
**Diagnosis**

[![][img_FD]][img_FD]

* Rome IV
	* ≥ 1 (1,3: PDS (食後愁訴症候群), 2,4: EPS (心窩部痛症候群))
		1. 食後のもられ感
		2. 早期飽満感
		3. 心窩部痛
		4. 心窩部灼熱感
	* –6moから起こる, ≥3mo症状が継続
	* 器質的疾患が上部内視鏡検査で確認されない

**Treatment**

* 初期
	* PPI / H~2~RA
	* [acotimide]
* 二次
	* 抗うつ
	* 抗不安
	* 漢方

<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->


## Gastric Cancer

**Etiology**

* EB virus

**Treatment**

* CCT
	* Primary
		* HER2(–)
			* [S-1] ( / [capecitabine]) + [CDDP] (/ [oxalliplatin])
		* HER2(+)
			* [capecitabine] (/ [S-1]) + [CDDP] (/ [oxalliplatin]) + [trastuzumab]
	* Secondary
		* [paclitaxel]
		* [irinotecan]
		* [ramucirumab]
	* Postope
* RT

## Anastomotic Ulcer

**Definition**

* 減酸が不十分な手術で吻合部の肛門側に
<!-- **Etiology** -->
<!-- *  -->
<!-- **Epidemiology** -->
<!-- *  -->
<!-- **Classification** -->
<!-- *  -->
<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->

**Treatment**

* H~2~RA
* PPI
<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->

## 

<!-- ## -->
<!-- <h6 id='-def'>Definition</h6> -->
<!-- <h6 id='-eti'>Etiology</h6> -->
<!-- <h6 id='-epi'>Epidemiology</h6> -->
<!-- <h6 id='-cls'>Classification</h6> -->
<!-- <h6 id='-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='-ass'>Association</h6> -->
<!-- <h6 id='-ex'>Examination</h6> -->
<!-- <h6 id='-dx'>Diagnosis</h6> -->
<!-- <h6 id='-tx'>Treatment</h6> -->
<!-- <h6 id='-prg'>Prognosis</h6> -->
<!-- <h6 id='-app'>Appendix</h6> -->

[acotimide]: .

[S-1]: . 
[capecitabine]: . 
[CDDP]: .
[oxalliplatin]: .
[trastuzumab]: .
[paclitaxel]: .
[irinotecan]: .
[ramucirumab]: .


[img_FD]: ../img/a_GE/FD.jpg

<style type="text/css">
	img{width: 51%; float: right;}
</style>